SpecGx LLC
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 381 & 385 Marshall Ave, Webster Groves, Missouri (MO) 63119, United States (USA)
- Operations here
- analysismanufacture
- FDA identifiers
- FEI 3005275960 · DUNS 828788054
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2023-09-18
- NAIBioresearch Monitoring2020-03-16
- NAIBioresearch Monitoring2019-03-06
- NAIDrug Quality Assurance2018-01-26
Drugs this plant is listed as making
1 distinct drugs across 6 products name this site in their FDA label.
- Lisdexamfetamine Dimesylatein shortageSpecGx LLC
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.